BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that the Company expects revenue for the fourth quarter ended December 31, 2005 to be approximately $19 million and the Company expects to be approximately cash flow neutral from operations for the quarter. The fourth quarter outlook announced today is unaudited and subject to change as a result of closing adjustments for the quarter.
